We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
2451
Acadia Healthcare
ACHC
$2.76B
$1K ﹤0.01%
28
-393
-93% -$17.4K
AEF
2452
abrdn Emerging Markets Equity Income Fund
AEF
$356M
$1K ﹤0.01%
+100
New +$713
AGEN
2453
Agenus
AGEN
$312M
$1K ﹤0.01%
9
-182
-95% -$12.8K
AMD icon
2454
Advanced Micro Devices
AMD
$776B
$1K ﹤0.01%
100
-700
-88% -$8.56K
AMKR icon
2455
Amkor Technology
AMKR
$12.4B
$1K ﹤0.01%
151
-191
-56% -$2.16K
ATRA icon
2456
Atara Biotherapeutics
ATRA
$75.5M
$1K ﹤0.01%
+4
New +$1.54K
AXR icon
2457
AMREP Corp
AXR
$123M
$1K ﹤0.01%
100
-50
-33% -$323
BNO icon
2458
United States Brent Oil Fund
BNO
$781M
$1K ﹤0.01%
+100
New +$1.36K
BXC icon
2459
BlueLinx
BXC
$422M
$1K ﹤0.01%
+100
New +$994
CARV
2460
DELISTED
Carver Bancorp
CARV
$1K ﹤0.01%
200
-36
-15% -$132
CGO
2461
Calamos Global Total Return Fund
CGO
$125M
$1K ﹤0.01%
+70
New +$889
CLDX icon
2462
Celldex Therapeutics
CLDX
$2.99B
$1K ﹤0.01%
+33
New +$1.46K
CLM icon
2463
Cornerstone Strategic Value Fund
CLM
$2.22B
$1K ﹤0.01%
+46
New +$738
COLL icon
2464
Collegium Pharmaceutical
COLL
$1.15B
$1K ﹤0.01%
100
-4,228
-98% -$41.8K
CPHC icon
2465
Canterbury Park Holding Corp
CPHC
$78.8M
$1K ﹤0.01%
50
+42
+525% +$439
CRT
2466
Cross Timbers Royalty Trust
CRT
$61.3M
$1K ﹤0.01%
60
-40
-40% -$620
CSWC icon
2467
Capital Southwest
CSWC
$1.47B
$1K ﹤0.01%
+70
New +$1.13K
CUZ icon
2468
Cousins Properties
CUZ
$5.19B
$1K ﹤0.01%
+25
New +$860
CWH icon
2469
Camping World
CWH
$639M
$1K ﹤0.01%
+34
New +$1K
DDS icon
2470
Dillards
DDS
$9.19B
$1K ﹤0.01%
13
-624
-98% -$33K
EBMT icon
2471
Eagle Bancorp Montana
EBMT
$187M
$1K ﹤0.01%
+29
New +$544
ELMD icon
2472
Electromed
ELMD
$337M
$1K ﹤0.01%
100
EPM icon
2473
Evolution Petroleum
EPM
$132M
$1K ﹤0.01%
+100
New +$780
FEIM icon
2474
Frequency Electronics
FEIM
$635M
$1K ﹤0.01%
133
-594
-82% -$5.98K
FHN icon
2475
First Horizon
FHN
$12.2B
$1K ﹤0.01%
50
-2,313
-98% -$41.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.